Related Experiment Video
Updated: Apr 10, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Microalbuminuria Is Associated With Left Ventricular Systolic Function in Newly Diagnosed Hypertensive Patients
Selim Aydemir1, Sidar Şiyar Aydın2, Onur Altınkaya1
1Department of Cardiology, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey.
Insights
Hypertension treatment improved cardiac function, with decreased urinary albumin creatinine ratio (UACR) linked to better left ventricular global longitudinal strain (LVGLS). UACR can monitor treatment effectiveness in hypertensive patients.
Area of Science:
- Cardiology
- Nephrology
- Hypertension Research
Background:
- Hypertension (HT) is a major global cardiovascular (CV) risk factor, often leading to cardiac dysfunction.
- Urinary albumin creatinine ratio (UACR) indicates microalbuminuria and predicts adverse CV events in HT patients.
Purpose of the Study:
- To investigate the relationship between UACR and cardiac function in newly diagnosed HT patients.
- To assess if UACR changes correlate with cardiac function improvements after treatment.
Main Methods:
- Prospective study of 104 newly diagnosed HT patients treated with ACEIs.
- Collected urine samples, 24-h BP monitoring, echocardiography (TTE), and LVGLS via speckle-tracking before and after 3 months of treatment.
- Linear regression analyzed UACR and cardiac parameter relationships.
Main Results:
- Treatment reduced blood pressure and UACR significantly.
- Decreased UACR showed a significant association with improved LVGLS.
- Microalbuminuria reduction correlated independently with LVGLS improvement.
Conclusions:
- A significant link exists between microalbuminuria (UACR) and LVGLS.
- Blood pressure control and UACR reduction in HT patients improve cardiac function.
- UACR is a potentially valuable marker for monitoring LV systolic function improvement.
Purpose:
Hypertension (HT) is a significant disease and cardiovascular (CV) risk factor worldwide. In patients with HT, cardiac dysfunction constitutes the main problem. Urinary albumin creatinine ratio (UACR), a practical measurement for diagnosing microalbuminuria, is associated with adverse CV events in HT patients. Our study aimed to examine the relationships between UACR and cardiac functions in newly diagnosed HT patients.
Methods:
Our study was designed prospectively. Patients diagnosed with HT were started on angiotensin-converting enzyme inhibitors (ACEIs) as treatment and were called for a follow-up after 3 months. Before and after treatment, spot urine samples, 24-h blood pressure monitoring, Conventional transthoracic echocardiography (TTE) parameters, and left ventricular global longitudinal strain (LVGLS) were calculated by Speckle-tracking echocardiography. A linear regression model evaluated the relationship between UACR and cardiac parameters measured on TTE.
Results:
Our study consists of 104 patients diagnosed with HT. The mean age of the patients was 49.1 ± 9.5 years, and 44.2% were male. With treatment, mean, night, and day systolic blood pressure (SBP), pulse pressure, and arterial pressure decreased, and these decreases were significantly associated with UACR. Additionally, microalbuminuria decreased with treatment, and an independent and significant association was observed between the decrease in UACR and the improvement in LVGLS in linear regression analysis.
Conclusion:
In our study, a significant relationship was observed between microalbuminuria and LVGLS. It was observed that treatments that reduce microalbuminuria and blood pressure control in HT patients were associated with improvement in LV functions, and UACR, which shows microalbuminuria, may be useful in monitoring the improvement in LV systolic functions.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome II : Assessment and Medical Management
Heart Failure II: Pathophysiology
Hypertension I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension II: Pathophysiology

